Senior Vice President
Thu, Jun 16, 2022
Jun 16
exercised or converted securities in APLS
10,000 shares @ $13.85
Increased holdings by +34.20%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology